Charles River Laboratories International Inc CRL:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:27 PM EDT
192.55quote price arrow down-0.37 (-0.19%)
Volume
269,081
52 week range
181.36 - 308.15
Loading...
  • Open192.86
  • Day High195.76
  • Day Low191.23
  • Prev Close192.92
  • 52 Week High308.15
  • 52 Week High Date04/08/22
  • 52 Week Low181.36
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap9.817B
  • Shares Out50.99M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-11.86

KEY STATS

  • Open192.86
  • Day High195.76
  • Day Low191.23
  • Prev Close192.92
  • 52 Week High308.15
  • 52 Week High Date04/08/22
  • 52 Week Low181.36
  • 52 Week Low Date09/27/22
  • Market Cap9.817B
  • Shares Out50.99M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-11.86

RATIOS/PROFITABILITY

  • EPS (TTM)9.48
  • P/E (TTM)20.32
  • Fwd P/E (NTM)18.84
  • EBITDA (TTM)954.845M
  • ROE (TTM)17.65%
  • Revenue (TTM)3.976B
  • Gross Margin (TTM)36.79%
  • Net Margin (TTM)12.39%
  • Debt To Equity (MRQ)91.09%

EVENTS

  • Earnings Date05/02/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Charles River Laboratories International Inc

Profile

MORE
Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and cells...
James Foster J.D.
Chairman of the Board, President, Chief Executive Officer
Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Flavia Pease
Chief Financial Officer, Corporate Executive Vice President
Joseph LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
William Barbo
Corporate Executive Vice President, Chief Commercial Officer
Address
251 Ballardvale St
Wilmington, MA
01887
United States

Top Peers

SYMBOLLASTCHG%CHG
EXAS
Exact Sciences Corp
63.20-0.24-0.38%
INCY
Incyte Corp
74.16+0.54+0.73%
NBIX
Neurocrine Biosciences Inc
97.17+2.92+3.10%
NVZMY
Novozymes A/S
48.95+0.25+0.51%
GRFS
Grifols SA
6.62-0.09-1.34%